Evotec (EVO) Institutional Ownership → Protect Yourself While There’s Still Time … (From Weiss Ratings) (Ad) Free EVO Stock Alerts $5.02 -0.08 (-1.57%) (As of 04/26/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Evotec (NASDAQ:EVO)CurrentInstitutional OwnershipPercentage5.81%Number ofInstitutional Buyers(last 12 months)3TotalInstitutional Inflows(last 12 months)$54.78MNumber ofInstitutional Sellers(last 12 months)3TotalInstitutional Outflows(last 12 months)$2.40M Get EVO Insider Trade Alerts Want to know when executives and insiders are buying or selling Evotec stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data EVO Institutional Buying and Selling by Quarter Ad Weiss RatingsProtect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.4 simple steps to protect your privacy and money before it’s too late. Evotec Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails3/5/2024Mubadala Investment Co PJSC4,597,701$53.93M0.2%N/A1.297% 2/13/2024Optiver Holding B.V.80,810$945K0.0%+643.1%0.023% 2/8/2024Quadrant Capital Group LLC2,130$25K0.0%N/A0.001% 1/31/2024Federated Hermes Inc.576,933$6.74M0.0%-0.3%0.163% 1/30/2024Zurcher Kantonalbank Zurich Cantonalbank174,266$2.04M0.0%-13.9%0.049% 11/13/2023Optiver Holding B.V.10,874$107K0.0%-68.0%0.003% 11/13/2023Federated Hermes Inc.578,533$5.71M0.0%-22.9%0.163% 10/25/2023Zurcher Kantonalbank Zurich Cantonalbank202,368$2.00M0.0%-6.2%0.057% (Data available from 1/1/2016 forward) EVO Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of EVO shares? During the previous two years, the following institutional investors and hedge funds held shares of Evotec shares: Mubadala Investment Co PJSC ($53.93M), Federated Hermes Inc. ($6.74M), Zurcher Kantonalbank Zurich Cantonalbank ($2.04M), and Optiver Holding B.V. ($945K), Quadrant Capital Group LLC ($25K).Learn more on EVO's institutional investors. What percentage of Evotec stock is owned by institutional investors? 5.81% of Evotec stock is owned by institutional investors. Learn more on EVO's institutional investor holdings. Which institutional investors have been buying Evotec stock? The following institutional investors have purchased Evotec stock in the last 24 months: Mubadala Investment Co PJSC ($4.60M), Optiver Holding B.V. ($69.94K), and Quadrant Capital Group LLC ($2.13K). How much institutional buying is happening at Evotec? Institutional investors have bought a total of 4,669,767 shares in the last 24 months. This purchase volume represents approximately $54.78M in transactions. Which Evotec major shareholders have been selling company stock? The following institutional investors have sold Evotec stock in the last 24 months: Federated Hermes Inc. ($173.07K), Zurcher Kantonalbank Zurich Cantonalbank ($41.40K), and Optiver Holding B.V. ($23.08K). How much institutional selling is happening at Evotec? Institutional investors have sold a total of 237,551 shares in the last 24 months. This volume of shares sold represents approximately $2.40M in transactions. Related Companies: Summit Therapeutics Major Shareholders Corcept Therapeutics Major Shareholders Merus Major Shareholders Janux Therapeutics Major Shareholders Vera Therapeutics Major Shareholders Rhythm Pharmaceuticals Major Shareholders Indivior Major Shareholders Arvinas Major Shareholders MorphoSys Major Shareholders Rocket Pharmaceuticals Major Shareholders This page (NASDAQ:EVO) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe World's First "$20 Trillion Drug?"Behind the MarketsEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsFed launches fourth dollar overhaulStansberry ResearchBiden out June 13; Kamala won’t replace him?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evotec SE Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.